Home | Media | Papers & Publications | Mailing List | Comments | Contact Me                                                                             Bookmark This Page
Dr. Treon is listed by US News & World Report as being in the top 1% of all doctors in the United States for his specialty. Please click the icon to go to his Top Docs web page.
Please visit our main program website:
Bing Center for Waldenstrom's Research. This site contains information on the latest treatment recommendations, abstracts, news and events, current and pending clinical trials and participating institutions, basic research, and publications, as well as photos and brief bios of the Bing Center staff.
WM Workshops: Starting with the first International
Workshop for WM in Washington DC in Sept. 2000, worshops have been
held bi-annually, the most recent in August of 2012 in Newport,
Rhode Island. The next workshop is scheduled for August 2014 in
London, UK. These workshops provide a venue for the WM
scientific community to collaborate and share their latest research
with the goal of advancing the knowledge of the genetic basis and
pathogenesis of WM, and the development of theraputics for this
malignancy. To learn more, please visit our WM Workshop Website.
Patient/Physician Summits: Starting with the first summit in
Boston in November, 2001, these conferences have provided a valuable
opportunity for patients, their families and caregivers to meet
face-to-face with the leaders of the WM scientific community. They
can learn the latest developments in the research and treatment of
WM, and also participate in working sessions and panel discussions.
To learn more, please visit our WM
How I Treat Waldenstrom's Macroglobulinemia: Dr. Treon's publication in the September 2009 Blood Journal, focused on the importance of individualized care of WM patients. CLICK HERE for the online article, or click on the picture below to download the publication.
Dedicated to the Discovery of the Cause and Cure of Waldenström’s Macroglobulinemia
Dr. Steven Treon is the Director of the Bing Center for Waldenström’s Research and an attending physician for medical oncology, at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, in Boston, Massachusetts. He is also an Associate Professor of Medicine at Harvard Medical School in Boston, and is the Chair of the Waldenström's Macroglobulinemia Clinical Trials Group.
After earning a doctorate in tumor immunology from Boston University (BU), Dr Treon did a postgraduate fellowship in the Department of Microbiology at BU School of Medicine. Dr Treon received a medical degree from BU School of Medicine and completed an internship in medicine and a residency in internal medicine at BU Medical Center. Dr Treon also served a clinical fellowship in hematology and oncology at Mass General Hospital and a research fellowship at Dana-Farber Cancer Institute and Harvard Medical School. He received certification from the American Board of Internal Medicine in 1995, and in medical oncology in 1997.
Dr Treon’s main research interests focus on understanding the genetic basis and pathogenesis of Waldenström’s macroglobulinemia and the development of therapeutics for this malignancy. He serves on the editorial boards of the Journal of Clinical Oncology, Blood, Clinical Cancer Research, and The Lancet. Dr Treon is a member of several professional societies including the American Medical Association, American Society of Hematology, American Society of Clinical Oncology, European Society of Hematology and the Massachusetts Medical Society. He has been honored with several research and academic awards from various national and international medical foundations and institutes, including the Robert A. Kyle Award for Waldenström's Macroglobulinemia.
Featured News Items
NE Support Group Meeting: Feb 5, 2012, Dana-Farber Jimmy Fund Auditorium: Dr. Treon's presentation on Waldenstrom's Macroglobulinemia - Genetic Basis & Therapy. Click this link to view the lecture.
The 7th International Workshop for Waldenstrom's
Macroglobulinemia and Symposium on Advances in Multiple Myeloma was held on
August 23-26, 2012 at the Hyatt Regency, Goat Island, in beautiful historic
Newport, Rhode Island, USA. Over 250 people attended this 4 day workshop which
included 14 sessions with 60 technical presentations from 70 speakers, including
6 debates, 22 poster presentations (including 6 oral presentations), 5
presentations and 1 debate on advances in Multiple Myeloma, and 2 consensus
IWWM-7 was our most comprehensive meeting to date, building upon all previous workshops. It reflects the continued growth in investigators working on the genetic basis, pathogenesis, and treatment of WM. Since the IWWM began in 2000, the number of participating investigators has steadily grown, as have also the number of WM related publications including those arising from the IWWM which have been published in Blood, Clinical Lymphoma Myeloma, Haematologica, Journal of Clinical Oncology, and Seminars in Oncology. A highlight of IWWM-7 was the research regarding MYD88 and its role as a major contributer to WM, and where the latest findings have been published in the August, 2012 edition of the New England Journal of Medicine.
We hope the IWWM-7 has enriched each attendees
understanding of Waldenstrom's Macroglobulinemia, and will help foster
discoveries leading to its cure.
Dr. Anders Waldenström son of Dr. Jan Waldenström, presents to Dr. Treon at the Nobel Hall, Stockholm, Sweden (2008) the award his late father received from the International Society of Hematology (ISH) in 1956 in Boston, MA. Also, the cover of the March, 2009 "special issue" of Clinical Lymphoma & Myeloma (of which Dr. Treon is guest editor) and contains the reports from the 5th International Workshop on WM, October 15-19, Stockholm, Sweden. Please visit the Media page which contains these and other photos from our recent conferences and events.